Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METRIC: Trametinib vs Chemotherapy in BRAF-mutant Melanoma
NCT01245062Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of trametinib in melanoma, sponsored by GSK. Started Nov 2010; status: completed.
02
Drugs
trametinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01245062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245062.